60 Degrees Pharmaceuticals (SXTP) stock

Worth $1.8MShares as of Aug 14

$0.52

-4.71%

As of Tuesday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score SXTP. It is too small and priced too low for a fair Quality Score.

Healthcare · Biotech

NextJan 2027“and secondary endpoint results are expected in January 2027”Trial data · SEC filing · Oct 6

Cash$1M, Under a quarter at the last year's spendingOn Jun 30

Follow SXTP's trial news. Pro members can get an alert when 60 Degrees Pharmaceuticals files news, and see its trials, share raises, and its CEO's filings.

Get an alert when SXTP files news on its trialsSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,168 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

Cash$1M, Under a quarter at the last year's spendingOn Jun 30

What's next for SXTP, and how long its cash lasts

Next step the company has named

Jan 2027“and secondary endpoint results are expected in January 2027”Trial data · SEC filing · Oct 6

What it means: the first look at a trial’s main results, as the company reports them.

A trial underway: TQ-BA-2024-3Phase 2 · Recruiting · 40 people · main data estimated Feb 2027 · NCT06656351

1 more trial, 46 filings, for Pro members.

Cash runway Jun 30 balance sheet

Under a quarter

$1M in cash and short-term investments, at its spending over the last year

What it means: how long the cash would last at the same pace, before any new money.

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

Shelf registration (S-3, filed Jul 12, 2024)
At-the-market share sales program (424B5, filed Mar 13, 2026)

For Pro members: 8 raises and their amounts, and the share count against a year ago.

Insiders

CEO Geoffrey S Dow bought 7,350 shares on Jun 12.

From Form 4: open-market buys and sales only.

Get an alert when Geoffrey Dow buys or sells

For Pro members: every trade, and Geoffrey Dow’s 9 filings and quotes.

Get an alert when SXTP files news on its trialsA free account. No card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 12 daysFDA decisionIn 12 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $500MDeramiocelFDA decision due (PDUFA)
In 12 daysFDA decisionIn 12 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $900MMolgramostimFDA decision due (PDUFA)
In 42 daysFDA decisionIn 42 days · FDA decisionMLYSMineralys TherapeuticsLorundrostatMLYSMineralys Therapeutics · $1.3BLorundrostatFDA decision due (PDUFA)

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

SXTP's latest filings

An agreement8-K, filed Nov 6
Quarterly report10-Q, filed Aug 14
Shelf registration, to sell securities laterS-3, filed Aug 14

29 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why SXTP isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. SXTP is worth about $1.8M and trades at $0.52. A stock that clears every mark is scored from the next weekly rebuild.

Straight AnswersStraight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.